Related Experiment Videos
Flavins as potential antimalarials. 1. 10-(Halophenyl)-3-methylflavins
W B Cowden1, I A Clark, N H Hunt
1John Curtin School of Medical Research, Australian National University, Canberra City.
Journal of Medicinal Chemistry
|April 1, 1988
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
Journal of Alzheimer's disease : JAD·2021
Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective - a Commentary.
Expert review of neurotherapeutics·2019
Intrusive memories to traumatic footage: the neural basis of their encoding and involuntary recall.
Psychological medicine·2015
Brain endothelial cells increase the proliferation of Plasmodium falciparum through production of soluble factors.
Experimental parasitology·2014
Structure-Guided Discovery of Novel Dual-Site FEM1B Ligands and Assessment of Their Use in Targeted Protein Degradation.
Journal of medicinal chemistry·2026
Targeting RNA-Binding Oncofetal Protein IGF2BP3: Discovery of Potent and Selective Inhibitors.
Journal of medicinal chemistry·2026
Circular Bivalent Aptamer Chimeras Leveraging LDLR-Mediated Lysosomal Shuttling for Targeted Protein Degradation.
Journal of medicinal chemistry·2026
Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus Penicillium herquei.
Journal of Asian natural products research·2026
The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.
Frontiers in behavioral neuroscience·2026
Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?
Expert opinion on pharmacotherapy·2026
Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.
Endocrine, metabolic & immune disorders drug targets·2026